Next Financial Group’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-35
Closed 2474
2019
Q1
$0 Hold
35
﹤0.01% 2325
2018
Q4
$0 Sell
35
-250
-88% -$124 ﹤0.01% 2216
2018
Q3
$0 Buy
+285
New +$153 ﹤0.01% 1565
2017
Q4
Sell
-335
Closed 1796
2017
Q3
$0 Buy
335
+235
+235% +$87 ﹤0.01% 2071
2017
Q2
$0 Buy
+100
New +$41 ﹤0.01% 2058
2017
Q1
Sell
-350
Closed 2577
2016
Q4
$0 Hold
350
﹤0.01% 2614
2016
Q3
$0 Buy
350
+250
+250% +$63 ﹤0.01% 2550
2016
Q2
$0 Hold
100
﹤0.01% 1983
2016
Q1
$0 Hold
100
﹤0.01% 2016
2015
Q4
$0 Hold
100
﹤0.01% 2100
2015
Q3
$0 Buy
100
+50
+100% +$17 ﹤0.01% 2105
2015
Q2
$0 Hold
50
﹤0.01% 2111
2015
Q1
$0 Hold
50
﹤0.01% 2098
2014
Q4
$0 Sell
50
-1,530
-97% -$1.04K ﹤0.01% 2737
2014
Q3
$1K Buy
+1,580
New +$767 ﹤0.01% 2494

Other funds holding GCVRZ

Next Financial Group's GCVRZ Position: Q2 2019 in Review

Next Financial Group sold out of Sanofi Contingent Value Rights (GCVRZ) in Q2 2019, closing a stake of 35 shares.

Next Financial Group first reported a position in GCVRZ in Q3 2014 and held it in 15 quarters. The position peaked at $1K in Q3 2014. 104 funds tracked by Wall St. Rank hold GCVRZ as of Q2 2019.

  • Next Financial Group reported no remaining Sanofi Contingent Value Rights position as of Q2 2019 after selling out during the quarter.
  • Next Financial Group sold 35 Sanofi Contingent Value Rights shares in Q2 2019.
  • Next Financial Group first reported a position in Sanofi Contingent Value Rights in Q3 2014 and held it in 15 quarters.
  • Next Financial Group's Sanofi Contingent Value Rights position peaked at $1K in Q3 2014.
  • 104 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q2 2019.

Based on Next Financial Group's 13F filing for Q2 2019, filed 16 Jul 2019.